All Centres From All Over the World Willing to Contribute Are Welcome
Brussels, Belgium
NCT Number: NCT03255109
WEAN SAFE (WorldwidE AssessmeNt of Separation of pAtients From ventilatory assistancE) is a multi-centre, prospective, observational, 4-week inception cohort study being carried out by the Acute Respiratory Failure section of ESICM. Weaning represents a challenge for intensivists and patients spend a considerable amount of time in being liberated from mechanical ventilation. While guidelines do exist on the classification of weaning, a recent study has shown that these may not be applicable to all patients. Moreover, different practices exist in regard to weaning procedures. WEAN SAFE will prospectively assess the burden of, management and spectrum of approaches to weaning from ventilation, in patients that require invasive mechanical ventilation for any reason, for a time period of at least 24 hours.
Looking for future studies?
Notify Me16 year and older
All sexes
Observational
Brussels, Belgium
The purpose of this study is to describe, in a large population of ICU patients the burden of, management and spectrum of approaches to weaning from ventilation, in patients that require invasive mechanical ventilation for any reason, for a time period of at least 24 hours. It will answer the following questions:
Patients will be screened for the study when undergoing mechanical ventilation and admitted in the ICU.
Day 1 will be defined as the first day when IMV commences Day 2 commences at 6-10am (fixed time point each day per ICU practice) after IMV commences. Patients undergoing invasive mechanical ventilation on the morning of day 1 will be screened for the study Patients still undergoing IMV on Day 2, will be enrolled in the study Patients not undergoing invasive mechanical ventilation or liberated from invasive mechanical ventilation on day 1 will be re-evaluated daily for the presence of inclusion criteria.
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Screening: all patients admitted in the ICU and aged >16 will be screened daily
Exclusion criteria
Time frame: 90 days or hospital discharge (whichever occurs first)
To describe the frequency of simple, difficult and prolonged weaning
Time frame: 90 days or hospital discharge (whichever occurs first)
What are the factors ((patient, institutional, medical practice) that are used to determine when patients are in the weaning phase
European Society of Intensive Care Medicine
Other
WEAN SAFE (WorldwidE AssessmeNt of Separation of pAtients From Ventilatory assistancE)
Acronym: WEAN SAFE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03415529
Acute Respiratory Distress Syndrome, Acute Severe Respiratory Failure
Brussels, Belgium
View Trial DetailsNCT02010073
Acute Respiratory Distress Syndrome, Acute Severe Respiratory Failure
Brussels, Belgium
View Trial DetailsNCT04663776
Acute Respiratory Distress Syndrome, Acute Respiratory Tract Infection
Boston, Massachusetts, United States
View Trial DetailsNCT05123755
Acute Respiratory Distress Syndrome, Bacterial Infections
Newport Beach, California, United States
View Trial Details